Bloom Health Partners Reports Profitable Fiscal Q3 2022 with $8.4 Million in Revenue

Bloom Health Partners Reports Profitable Fiscal Q3 2022 with $8.4 Million in Revenue

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces unaudited Fiscal Q2 2022 revenues of CAD $8.4M for the three months ended June 30th, 2022, bringing year-to-date revenues to CAD $24.9M for the first three quarters of Fiscal 2022.

Highlights in Fiscal Q2 2022:

  • Revenues CAD $8.4M
  • Adjusted EBITDA(1) CAD $1.4M
  • Cash on hand end at June 30, 2022 of CAD $5.9M with receivables of CAD $6.8M
  • Fiscal 2022 YTD revenues CAD $24.9M, with announced revenue guidance for the full fiscal year of CAD $25M - CAD $28M
  • Announced extension with State of Texas K-12 Schools for an additional year

Full results available at www.sedar.com.

"We're thrilled to announce our third quarter results," said Andrew Morton, CEO of Bloom. "Our Fiscal Q3 2022 revenue of CAD $8.4M and aggregate CAD $24.9M year to date has resulted in us all but reaching our revenue guidance for FY 2022 in three quarters. We're proud of our team's performance so far this year as we continue to transition Bloom into an innovative provider of employer health-tech solutions and services. Our end-to-end platform strategy of clinical, labs and data in workplace health is well received by clients, partners and investors."

(1) This is a non-IFRS measure. Refer to the section "Non-IFRS Financial Measures" for information on the calculation of this non-IFRS measures.
(2)
Refer to the section "Disclosure on Financial Guidance" for additional information.

Non-IFRS Financial Measures

We believe that providing certain non-IFRS financial measures provide users with important information regarding the operational performance of our business. The non-IFRS financial measures used by management do not have any standardized meaning prescribed by IFRS and therefore may not be comparable to similar measures presented by other issuers. Accordingly, these measures should not be considered as a substitute or alternative for IFRS measures as determined in accordance with IFRS. By considering these measures in combination with the comparable IFRS financial measures, we believe that users are provided a better overall understanding of our business and financial performance during the relevant period than if they considered the IFRS financial measures alone.

EBITDA

EBITDA is defined as earnings before interest, income taxes, depreciation, and amortization and is utilized by management to assess and evaluate the financial performance of its operations. Management believes that EBITDA improves comparability between periods by eliminating the impact of interest, income taxes, depreciation, and amortization.

Adjusted EBITDA excludes items that are not considered to be indicative of operational and financial trends either by nature or amount to provide a better overall understanding of the Company's underlying business performance. The most directly comparable GAAP measure to EBITDA and Adjusted EBITDA is net income before tax, calculated as follows:

The most directly comparable GAAP measure to EBITDA is net income before tax, calculated as follows:

For the three months ended
June 30
20222021
Net income before tax$31,492$(1,065,599)
     Amortization of intangibles706,453-
     Depreciation120,095-
     Interest expense391,181-
EBITDA1,249,221(1,065,599)
     Debt modification gain(130,033)-
     Fair value loss on contingent consideration274,642-
Adjusted EBITDA$1,393,830$(1,065,599)

 

Disclosure on Financial Guidance

Anticipated revenue figures and EBITDA are based on modelling and estimates developed by management and updated as of June 30, 2022. These estimates are based on our Fiscal Year 2021 results and year-to-date 2022 results, including market size, and assume only ongoing business, as well as marginal growth in fixed costs through Fiscal Year 2022. Readers are cautioned that actual results could differ materially from these estimates based on increases in operating costs, failure to maintain regulatory licensing, inability to execute on existing contracts with schools in Texas, failure to attract and retain qualified employees, or a reduction in customer demand.

About Bloom Health Partners Inc.

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) is a global platform for healthcare security, diagnostic testing and occupational health-tech. Our mission is to ensure that "unstoppable is possible" for businesses and their employees through innovative, customized healthcare models. Bloom offers a system for businesses and organizations that helps engage employees and creates strategies to manage health and safety. Our stable, scalable system is an integrated health-tech platform that securely manages data while delivering comprehensive workplace health and safety outcomes.

For more information: investors@bloomhealthpartners.com

On behalf of the board of directors,

Bloom Health Partners Inc.

Andrew Morton, Chief Executive Officer

Forward-Looking Statements

This news release includes forward-looking statements that are subject to risks and uncertainties. All statements within, other than statements of historical fact, are to be considered forward looking. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results or developments may differ materially from those in forward-looking statements. Factors that could cause actual results to differ materially from those in the Company's forward-looking statements include the potential that milestones may not be satisfied, acquisitions may not achieve expected benefits, financing requirements, and the other risk factors described in the Company's filings with Canadian securities regulators on www.sedar.com. There can be no assurances that such statements will prove accurate and, therefore, readers are advised to rely on their own evaluation of such uncertainties. We do not assume any obligation to update any forward-looking statements except as required under the applicable laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/135425

News Provided by Newsfile via QuoteMedia

BLMH:CNX
The Conversation (0)
Bloom Health Partners Announces Leadership Transition

Bloom Health Partners Announces Leadership Transition

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of diagnostic and health technology services, announces a leadership transition.

Effective September 30, 2022, Andrew Morton has stepped down as CEO of the Company to pursue other opportunities. Rosemary Elliston, COO of the Company, has been appointed to the position of Interim CEO. Mr. Morton will continue to support the Company as a Director.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners Announces New Location in Hawaii

Bloom Health Partners Announces New Location in Hawaii

New Bloom lab will support operations in the Honolulu area and surrounding region

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces the opening of a new location in in the Honolulu area.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners CEO to Speak at Health Benefits Nation Conference in Orlando

Bloom Health Partners CEO to Speak at Health Benefits Nation Conference in Orlando

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces its CEO, Andrew Morton, will speak on a panel at Health Benefits Nation Conference in Orlando, Florida on September 15th, 2022.

Mr. Morton will join co-panelists Eric Hargan, former U.S. Federal Deputy Secretary of the Department of Health and Human Services (DHHS), and Jeff Hogan, President of Upside Health Advisors. The panel titled "Incorporating Occupational Health into Value Based Health Strategies" will focus on workplace health and using data models to improve outcomes in occupational health in such areas as preventive care and mental health.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners Announces New Location to Serve Chicago and Surrounding Area

Bloom Health Partners Announces New Location to Serve Chicago and Surrounding Area

New Bloom lab in the Chicago area will serve as a foothold in the midwestern United States

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D84) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces the opening of a new location in the Chicago area.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
Bloom Health Partners Announces Closing of Second Tranche of Private Placement for over C$1.58M in Aggregate Gross Proceeds

Bloom Health Partners Announces Closing of Second Tranche of Private Placement for over C$1.58M in Aggregate Gross Proceeds

Bloom Health Partners Inc. (CSE: BLMH) (OTCQB: BLMHF) (FSE: D840) ("Bloom" or the "Company"), a leading provider of operational health and health technology, announces that it has closed the second tranche of its previously announced non-brokered private placement offering (the "Offering") and has issued 2,770,000 units (the "Units") at $0.20 per Unit for gross proceeds of C$554,000. Combined with the first tranche of the Offering, the Company has sold 7,920,000 Units of the Company for aggregate gross proceeds of C$1,584,000. The Units are comprised of (i) one (1) common share in the capital of the Company ("Common Shares"); and (ii) one-half (12) of a transferable common share purchase warrant (each whole warrant, a "Warrant" and collectively, the "Warrants"). Each Warrant entitles the holder thereof to acquire one (1) additional Common Share (each, a "Warrant Share") in the capital of the Company at a price of $0.30 per Warrant Share until July 18, 2023. The net proceeds of the Offering will be used by the Company for ongoing working capital and corporate development.

News Provided by Newsfile via QuoteMedia

Keep reading...Show less
ARway.ai The Spatial Computing Company Signs New Deal With Kuwait Agency For AR Navigation

ARway.ai The Spatial Computing Company Signs New Deal With Kuwait Agency For AR Navigation

ARway.ai ("ARway" or the "Company") (CSE:ARWY)(OTCQB:ARWYF)(FSE:E65) is an AI powered Augmented Reality Experience platform with a disruptive no-code, no beacon spatial computing solution enabled by visual marker tracking with centimeter precision is pleased to announce a new deal with AMANAH TEKNOLOGIA, located in Kuwait City, Kuwait. They are another ARway.ai partner, leading technology company and system integrator that provides innovative products to enhance the way businesses and people interact with technology; software development, cloud hosting, e-commerce and marketing

This deal encompasses a project to prototype mobile application for hospitals that integrates with EMR systems and acts as a digital concierge for visitors and staff. The prototype will be tested at the Dar AlShifa Hospital in Kuwait, which will leverage the ARwayKit SDK to provide AR navigation and immersive educational experiences throughout the entire facility. This ensures the hospital journey is as easy and seamless as possible.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
ARway.ai Expanding Its Spatial Computing Platform, Hires New AI Computer Vision and Machine Learning Ph.D Engineer

ARway.ai Expanding Its Spatial Computing Platform, Hires New AI Computer Vision and Machine Learning Ph.D Engineer

ARway.ai ("ARway" or the "Company") (CSE:ARWY)(OTCQB:ARWYF)(FSE:E65) is an AI powered Augmented Reality Experience platform with a disruptive no-code, no beacon spatial computing solution enabled by visual marker tracking with centimeter precision is excited to announce Soumic Sarkar as a new Computer Vision and Machine Learning Engineer to its existing team bringing its total AI team to eleven as it ramps up its spatial computing platforms capabilities. With a distinguished background in robotics and machine learning, Mr. Sarkar brings a wealth of experience from prestigious institutions and leading-edge projects

With an academic foundation holding a Ph.D. in Control and Automation from the Indian Institute of Technology Delhi, and a rich professional history that includes contributions to robotic navigation, sensor fusion, and autonomous systems design, Mr. Sarkar's expertise is set to propel ARway.ai's spatial computing platform to new heights.

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
person with a neuralink brain chip

Can You Invest in Elon Musk’s Neuralink?

In recent weeks, Elon Musk's Neuralink has captured the public’s attention and imagination with its futuristic vision of connecting the human brain to computers.

As Neuralink, which is registered as a medical research company, continues to make strides, investors are wondering how to get a piece of the action by investing in the neurotechnology venture.

Because it is privately held, Neuralink isn't accessible to the average person — but that doesn't mean getting exposure is impossible. Read on to learn how to participate in the growth of this exciting business.

Keep reading...Show less
Nextech3D.ai Expands AI Tech Team and Doubles Office Space as Demand Increases for GPT AI Platform and 3D Model Production in Hyderabad, India

Nextech3D.ai Expands AI Tech Team and Doubles Office Space as Demand Increases for GPT AI Platform and 3D Model Production in Hyderabad, India

Company is Negotiating Major Licensing Deals For its GPT AI 3D Modeling Technology

Nextech3D.ai (OTCQX:NEXCF)(CSE:NTAR)(FSE:1SS), a Generative GPT AI-Powered 3D model supplier for Amazon, P&G, Kohls, Miele and others including major e-commerce platform integrations with Shopify, BigCommerce and WooCommerce is pleased to announce the expansion of its AI tech team by doubling its office space in Hyderabad, India, to accommodate its expanding team. The Company is also in negotiations for a major license of its GPT AI 3D modeling CAD to 3D and texturing technology. Nextech3D.ai will continue to supply 3D models to the largest brands and .platforms as it gears up increasing revenue and profit margins by signing licensing deals with global manufactures that have CAD files.3D GPT AI Licensing TechnologyThe Company's strategic move to license its GPT AI tech is set to remove the traditional barriers of price and volume that have long restricted the accessibility of high-quality 3D modeling technology for e-commerce and other industries. Nextech3D.ai has leveraged its groundbreaking GPT AI powered technology to dramatically slash the cost of 3D models from CAD files to $10 to 20 while producing the highest quality 4K quad mesh photo realistic models, enabling scalability while being highly profitable

News Provided by ACCESSWIRE via QuoteMedia

Keep reading...Show less
Nextech3D.ai Featured in Syndicated Broadcast Highlighting Launch of Next Era of GPT AI 3D Solutions

Nextech3D.ai Featured in Syndicated Broadcast Highlighting Launch of Next Era of GPT AI 3D Solutions

Via IBNNextech3D.ai (CSE: NTAR) (OTCQX: NEXCF) (FSE: 1SS) a Generative AI-Powered 3D model supplier for Amazon, P&G, Kohls, Miele and others including major e-commerce platform integrations with Shopify, BigCommerce and WooCommerce, today announces that it has been featured in a broadcast via NetworkNewsAudio ("NNA"), a solution that delivers additional visibility, recognition and brand awareness in the investment community via distribution to thousands of syndication points. The audio news release covers Nextech3D.ai's recent announcement of the launch of the next era of GPT AI 3D product solutions leveraging proprietary algorithms.

To hear the audio production, visit: https://www.nnw.fm/VFivh

News Provided by GlobeNewswire via QuoteMedia

Keep reading...Show less
XReality Group

xReality Group expands Operator XR to Mexican Market

xReality Group Limited (ASX:XRG) is pleased to announce that it has formalised a partnership with a key technology partner in Mexico for the distribution of Operator XR’s VR technology for Law Enforcement and Military markets.

Tecnología en Sistemas de Apoyo SA (TSA) are a trusted provider to State Police and Judicial agencies across Mexico, having successfully designed, built and implemented the standard judicial recording system used across the majority of Mexican states. Founded in 1999, TSA is a skilled technology services company, trusted by Mexico state agencies, and offers Operator XR access into key Law Enforcement Agencies across Mexico.

Keep reading...Show less

Latest Press Releases

Related News

×